GNMLF
Price
$1.17
Change
+$0.08 (+7.34%)
Updated
Jul 29 closing price
Capitalization
1.12B
VEXTF
Price
$0.18
Change
+$0.01 (+5.56%)
Updated
Aug 15 closing price
Capitalization
46.8M
Interact to see
Advertisement

GNMLF vs VEXTF

Header iconGNMLF vs VEXTF Comparison
Open Charts GNMLF vs VEXTFBanner chart's image
Genomma Lab International SAB DE CV
Price$1.17
Change+$0.08 (+7.34%)
Volume$100
Capitalization1.12B
Vext Science
Price$0.18
Change+$0.01 (+5.56%)
Volume$24.7K
Capitalization46.8M
GNMLF vs VEXTF Comparison Chart in %
Loading...
GNMLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VEXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNMLF vs. VEXTF commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNMLF is a Hold and VEXTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (GNMLF: $1.17 vs. VEXTF: $0.19)
Brand notoriety: GNMLF and VEXTF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GNMLF: 12% vs. VEXTF: 49%
Market capitalization -- GNMLF: $1.12B vs. VEXTF: $46.8M
GNMLF [@Pharmaceuticals: Generic] is valued at $1.12B. VEXTF’s [@Pharmaceuticals: Generic] market capitalization is $46.8M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNMLF’s FA Score shows that 1 FA rating(s) are green whileVEXTF’s FA Score has 1 green FA rating(s).

  • GNMLF’s FA Score: 1 green, 4 red.
  • VEXTF’s FA Score: 1 green, 4 red.
According to our system of comparison, VEXTF is a better buy in the long-term than GNMLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNMLF’s TA Score shows that 5 TA indicator(s) are bullish while VEXTF’s TA Score has 4 bullish TA indicator(s).

  • GNMLF’s TA Score: 5 bullish, 2 bearish.
  • VEXTF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GNMLF is a better buy in the short-term than VEXTF.

Price Growth

GNMLF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while VEXTF (@Pharmaceuticals: Generic) price change was +8.82% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNMLF($1.12B) has a higher market cap than VEXTF($46.8M). GNMLF has higher P/E ratio than VEXTF: GNMLF (11.52) vs VEXTF (5.78). VEXTF YTD gains are higher at: 63.572 vs. GNMLF (-7.874). GNMLF has higher annual earnings (EBITDA): 4.02B vs. VEXTF (1.18M). GNMLF has more cash in the bank: 2.59B vs. VEXTF (4.83M). VEXTF has less debt than GNMLF: VEXTF (37.4M) vs GNMLF (7.2B). GNMLF has higher revenues than VEXTF: GNMLF (18.8B) vs VEXTF (39.2M).
GNMLFVEXTFGNMLF / VEXTF
Capitalization1.12B46.8M2,395%
EBITDA4.02B1.18M340,186%
Gain YTD-7.87463.572-12%
P/E Ratio11.525.78199%
Revenue18.8B39.2M47,959%
Total Cash2.59B4.83M53,626%
Total Debt7.2B37.4M19,251%
FUNDAMENTALS RATINGS
GNMLF vs VEXTF: Fundamental Ratings
GNMLF
VEXTF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
51
Fair valued
PROFIT vs RISK RATING
1..100
81100
SMR RATING
1..100
6195
PRICE GROWTH RATING
1..100
5335
P/E GROWTH RATING
1..100
8517
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GNMLF's Valuation (9) in the null industry is somewhat better than the same rating for VEXTF (51). This means that GNMLF’s stock grew somewhat faster than VEXTF’s over the last 12 months.

GNMLF's Profit vs Risk Rating (81) in the null industry is in the same range as VEXTF (100). This means that GNMLF’s stock grew similarly to VEXTF’s over the last 12 months.

GNMLF's SMR Rating (61) in the null industry is somewhat better than the same rating for VEXTF (95). This means that GNMLF’s stock grew somewhat faster than VEXTF’s over the last 12 months.

VEXTF's Price Growth Rating (35) in the null industry is in the same range as GNMLF (53). This means that VEXTF’s stock grew similarly to GNMLF’s over the last 12 months.

VEXTF's P/E Growth Rating (17) in the null industry is significantly better than the same rating for GNMLF (85). This means that VEXTF’s stock grew significantly faster than GNMLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GNMLFVEXTF
RSI
ODDS (%)
Bearish Trend 3 days ago
42%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
35%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
19%
Bullish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
25%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
25%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
23%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
33%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GNMLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VEXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEDIX32.060.09
+0.28%
Franklin Mutual Global Discovery A
JHAAX10.310.01
+0.10%
JHancock Multi-Asset Absolute Return A
RAAAX9.88-0.01
-0.10%
Altegris/AACA Opportunistic Real Estt A
MLPFX8.89-0.05
-0.56%
Invesco SteelPath MLP Select 40 A
LISGX71.27-0.57
-0.79%
ClearBridge Small Cap IS

GNMLF and

Correlation & Price change

A.I.dvisor tells us that GNMLF and AQST have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNMLF and AQST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNMLF
1D Price
Change %
GNMLF100%
N/A
AQST - GNMLF
21%
Poorly correlated
N/A
LVRLF - GNMLF
20%
Poorly correlated
+19.28%
VEXTF - GNMLF
20%
Poorly correlated
+2.72%

VEXTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VEXTF has been loosely correlated with TCNNF. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VEXTF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VEXTF
1D Price
Change %
VEXTF100%
+2.72%
TCNNF - VEXTF
40%
Loosely correlated
-7.35%
CURLF - VEXTF
37%
Loosely correlated
-9.48%
GTBIF - VEXTF
37%
Loosely correlated
-12.40%
GLASF - VEXTF
34%
Loosely correlated
-6.40%
JUSHF - VEXTF
32%
Poorly correlated
-10.65%
More